[The treatment of non-Hodgkin's lymphomas taking into account individual sensitivity to the chemical preparations].
Polychemotherapy is a mainstay in the treatment of lymphoproliferative diseases. At the department of systemic tumour diseases there have been examined as many as 63 patients with malignant lymphomas; individual sensibility was studied to antitumour drug preparations as recommended by V. P. Evtukh, A. S. Zverkova (1984). After courses of polychemotherapy devised with taking in account the individual sensibility, the immediate results and a parameter characterizing the relapse-free survival got improved as compared with treatments administered according to standard strategies, particularly so in patients with non-Hodgkin's lymphomas presenting with high degree malignancy in the stage of dissemination.